03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Employers have a regulatory duty to promptly report workplace injuries such as employee fatalities, ...
Read More >
Uncertainty continues to loom over the M&A market as organizations that were actively involved in tr...
Read More >
Sabre Likely to Face Anti-Trust Challenge - ("DOJ Poised to Sue to Block Sabre’s Deal for Farelog...
Read More >
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
On September 3, 2020, the U.S. Department of Justice Antitrust Division released a revised Merger Re...
Read More >
In Ferra v. Loews Hollywood Hotel, LLC, the California Court of Appeal considered the method for det...
Read More >